Company news
Ixico Plc (LSE:IXI) news
Every Ixico Plc press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
HD Industry Update
July 13, 2026
Exercise of Options
June 19, 2026
Scientific advisors & partners update
June 8, 2026
Company presentation at Mello 2026
May 22, 2026
Contract win and contract extension
May 21, 2026
Interim results for six months ending 31/03/2026
May 19, 2026
IXICO Updates AI Neuroimaging Platform
May 12, 2026
Result of GM and Update on Issue of Equity
April 16, 2026
Placings and Subscription
March 31, 2026
Collaboration with Medidata
March 26, 2026
Validation of Neuroimaging Technology Platform
February 26, 2026
Correction: c.£1.5 million Contract Extension
February 12, 2026
c.£1.5 million Contract Extension
February 12, 2026
Appointment of Chief Commercial Officer
February 5, 2026
Results of AGM
January 23, 2026
Share option award
December 9, 2025
Financial Results for year ended 30 September 2025
December 9, 2025
Operational Update
December 1, 2025
Notice of 2025 Full Year Results and IMC
November 27, 2025
Clinical Trial Contract Win
November 17, 2025
Capital Markets Day Presentation and Video
November 3, 2025
Trading Update
October 16, 2025
New contract win and contract extension
October 15, 2025
Notice of Capital Markets Day
September 30, 2025
Contract Win
August 12, 2025
Strategic Data Partnership with GAP
July 22, 2025
Share option awards and PDMR Dealing
June 13, 2025
FDA Clearance of Alzheimer's Diagnostic Biomarker
June 10, 2025
IXICO : assists first FDA clearance of new Alzheimer’s Disease blood based diagnostic biomarker
June 5, 2025
Holding(s) in Company
May 20, 2025
Half-year Report
May 20, 2025
Notice of Interim Results & Investor Presentation
May 6, 2025
IXICO : Half year Trading update FY2025
April 16, 2025
Further Validation of IXICO’s AI Imaging Platform
February 12, 2025
Issue of share options and PDMR dealing
February 7, 2025
Result of AGM
January 24, 2025
Commercial agreement with PETNET Solutions Inc
December 16, 2024
IXICO : US Client Clinical Trial Contract Win
December 10, 2024
Share Option Award & PDMR Dealings
December 4, 2024
Financial Results for year ended 30 September 2024
December 4, 2024
Notice of Results and Investor Presentation
November 25, 2024
Share Option Awards & PDMR Dealing
October 31, 2024
Director/PDMR Shareholdings
October 28, 2024
Result of GM, Issue of Equity & TVR
October 25, 2024
Correction of clerical error
October 22, 2024
Director/PDMR Shareholding
October 16, 2024
Result of Retail Offer
October 15, 2024
Exercise of Options & Director/PDMR Purchase
October 10, 2024
Result of Placing and Subscription
October 9, 2024
Retail Offer
October 8, 2024